Clovis Oncology (CLVS) Misses Q4 EPS by 32c

Clovis Oncology (NASDAQ: CLVS) reported Q4 EPS of ($1.62), $0.32 worse than the analyst estimate of ($1.30).

For earnings history and earnings-related data on Clovis Oncology (CLVS) click here.

You May Also Be Interested In

• Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
• Arca Biopharma (ABIO) Reports Q1 Loss of $0.14
• Intel slides in afterhours trading as Q1 revenue misses, Q2 outlook falls short